| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I USD | RVI EMERGENTES | 36,22% | 90,28% | 90,78% | 210,56% |
| GOLDMAN SACHS US EQUITY ESG PORTFOLIO R USD CAP | RVI USA | 13,86% | 45,08% | 53,31% | 210,25% |
| ROBECO QI GLOBAL DEVELOPED 3D ENHANCED INDEX EQUITIES F EUR | RVI GLOBAL | 19,23% | 64,72% | 76,74% | 210,22% |
| MFS MERIDIAN U.S. CONCENTRATED GROWTH FUND W1-USD | RVI USA CRECIMIENTO | 2,49% | 20,26% | 27,44% | 210,21% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES US2 | RVI EUROPA | 14,65% | 95,75% | 133,60% | 210,18% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES U | RVI EUROPA | 14,84% | 95,74% | 133,00% | 210,14% |
| T.ROWE GLOBAL VALUE EQUITY FUND I | RVI GLOBAL VALOR | 35,66% | 76,33% | 91,75% | 210,04% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES R | RVI EUROPA | 14,83% | 95,73% | 133,00% | 210,02% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 45,58% | 72,57% | 76,21% | 209,91% |
| T.ROWE US EQUITY FUND A | RVI USA | 14,50% | 50,35% | 64,22% | 209,89% |
